The importance of commutability in material used for quality control purposes
- 5 September 2018
- journal article
- research article
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 41 (1), 39-45
- https://doi.org/10.1111/ijlh.12918
Abstract
External Quality Assessment (EQA) is an important part of laboratory quality assurance. Spiking of normal plasma is sometimes employed to mimic clinical samples. It is important that spiked material gives similar results to clinical samples (ie, is commutable) to ensure appropriate conclusions can be drawn from EQA exercises. We describe here data from UK National External Quality Assessment Scheme for Blood Coagulation (NEQAS BC) exercises where spiked samples were tested alongside samples from patients to explore commutability of artificial material. Normal plasma was spiked with unfractionated heparin (UFH), low molecular weight heparin (LMWH), Dabigatran or Rivaroxaban. Factor VIII (FVIII) deficient plasma was spiked with FVIII concentrate. Spiked samples and ex vivo patient material were sent to laboratories for testing. For LMWH, good agreement was seen between results for samples from patient plasma and plasma spiked with heparin. For UFH, APTT ratios differed between spiked and patient samples for the same drug concentration, with no correlation in ranking of reagents. Precision for patient and spiked material for Rivaroxaban and Dabigatran assays was comparable. However, the pattern of results for some Dabigatran assay kits differed between spiked and patient samples. For FVIII assays, results obtained with spiked and postinfusion samples gave comparable results. Spiked material is suitable for EQA if commutability is demonstrated. Our data show commutability for plasma spiked with Rivaroxaban, LWMH and some FVIII concentrates. For some tests, notably APTT for UFH, marked differences between patient and spiked samples indicate not all tests can be evaluated using artificial samples.Keywords
This publication has 14 references indexed in Scilit:
- A Multilaboratory Commutability Evaluation of Proficiency Testing Material for Carbamazepine and Valproic AcidTherapeutic Drug Monitoring, 2015
- Stability of coagulation proteins in lyophilized plasmaInternational Journal of Laboratory Hematology, 2014
- Problems and Solutions in Laboratory Testing for HemophiliaSeminars in Thrombosis and Hemostasis, 2013
- Proficiency Testing/External Quality Assessment: Current Challenges and Future DirectionsClinical Chemistry, 2011
- Quality Control in Coagulation TestingSeminars in Thrombosis and Hemostasis, 2008
- Quality Assessment of CoaguChek Point-of-Care International Normalized Ratio Monitors: A Note of CautionClinical Chemistry, 2007
- Why Commutability MattersClinical Chemistry, 2006
- Multilaboratory Testing in Thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance ProgramSeminars in Thrombosis and Hemostasis, 2005
- Stability of coagulation proteins in frozen plasmaBlood Coagulation & Fibrinolysis, 2001
- Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage.Journal of Clinical Pathology, 1996